Evidence map›Paper›PMID 21196331›Full record

ArticleFrontiers in bioscience (Elite edition)2011

Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells.

Rakesh K Srivastava, Su-Ni Tang, Wenyu Zhu, Daniel Meeker, Sharmila Shankar

Open access · bronzeAbstract read
In one paragraph

Article in Frontiers in bioscience (Elite edition), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 123 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Cells · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells.International journal of molecular sciences · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rakesh K SrivastavaDepartment of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, KS 66160, USA. rsrivastava@kumc.edu
Su-Ni Tang
Wenyu Zhu
Daniel Meeker
Sharmila Shankar
The University of Kansas Cancer Center · US

Funding

Chemoprevention of Pancreatic Cancer by EGCGR01CA125262 · NCI · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI DHAR, ANIMESH · 2008 to 2012
$1.7M
Mechanisms of Chemoprevention by ResveratrolR01CA114469 · NCI · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI SRIVASTAVA, RAKESH K. · 2005 to 2009
$726k
NCI NIH HHS R01 CA114469NCI NIH HHS R01CA114469NCI NIH HHS R01 CA125262NCI NIH HHS R01CA125262NCI NIH HHS R01CA125262-02S1
6 · The paper itself

Abstract

According to the cancer stem cell hypothesis, the aggressive growth and early metastasis of cancer may arise through dysregulation of self-renewal of stem cells. The objectives of this study were to examine the molecular mechanisms by which sulforaphane (SFN, an active compound in cruciferous vegetables) inhibits self-renewal capacity of pancreatic cancer stem cells (CSCs), and synergizes with quercetin, a major polyphenol and flavonoid commonly detected in many fruits and vegetables. Our data demonstrated that SFN inhibited self-renewal capacity of pancreatic CSCs. Inhibition of Nanog by lentiviral-mediated shRNA expression enhanced the inhibitory effects of sulforaphane on self-renewal capacity of CSCs. SFN induced apoptosis by inhibiting the expression of Bcl-2 and XIAP, phosphorylation of FKHR, and activating caspase-3. Moreover, SFN inhibited expression of proteins involved in the epithelial-mesenchymal transition (beta-catenin, vimentin, twist-1, and ZEB1), suggesting the blockade of signaling involved in early metastasis. Furthermore, the combination of quercetin with SFN had synergistic effects on self-renewal capacity of pancreatic CSCs. These data suggest that SFN either alone or in combination with quercetin can eliminate cancer stem cell-characteristics.

Indexed as

Analysis of VarianceApoptosisBlotting, WesternCell Line, TumorDrug SynergismGenetic VectorsHomeodomain ProteinsHumansIsothiocyanatesLentivirusNanog Homeobox ProteinNeoplastic Stem CellsPancreatic NeoplasmsProto-Oncogene Proteins c-bcl-2QuercetinSulfoxidesHomeodomain ProteinsIsothiocyanatesNanog Homeobox ProteinNANOG protein, humanProto-Oncogene Proteins c-bcl-2QuercetinsulforaphaneSulfoxidesThiocyanatesXIAP protein, humanX-Linked Inhibitor of Apoptosis Protein

Identifiers

PMID21196331
PMCPMC4080794
OpenAlexW185057651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.